Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Conditions
- Chronic Lymphocytic Leukaemia (CLL)
- Multiple Myeloma (MM)
- Secondary Immunodeficiency (SID)
Sponsor
Medical University Innsbruck